Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin.
Clicks: 106
ID: 119378
1993
We performed a randomized, controlled trial of intravenous immune globulin (respiratory syncytial virus [RSV] neutralizing [Nt] antibody titer of 1:950 in 5% solution) to evaluate protection against RSV-induced disease over two respiratory virus seasons. ...
| Reference Key |
snydman1993antimicrobialcontrolled
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | H C Meissner, D R Fulton, J R Groothuis, R L Geggel, G R Marx, V G Hemming, T Hougen, D R Snydman;H C Meissner;D R Fulton;J R Groothuis;R L Geggel;G R Marx;V G Hemming;T Hougen;D R Snydman; |
| Journal | Antimicrobial agents and chemotherapy |
| Year | 1993 |
| DOI | 10.1128/aac.37.8.1655 |
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.